| Literature DB >> 35813872 |
Michael Overduin1, Troy A Kervin1, Anh Tran1.
Abstract
Membrane recognition by viral spike proteins is critical for infection. Here we show the host cell membrane-binding surfaces of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike variants Alpha, Beta, Gamma, Delta, Epsilon, Kappa, and Omicron as well as SARS-CoV-1 and pangolin and bat relatives. They show increases in membrane binding propensities over time, with all spike head mutations in variants, and particularly BA.1, impacting the protein's affinity to cell membranes. Comparison of hundreds of structures yields a progressive model of membrane docking in which spike protein trimers shift from initial perpendicular stances to increasingly tilted positions that draw viral particles alongside host cell membranes before optionally engaging angiotensin-converting enzyme 2 (ACE2) receptors. This culminates in the assembly of the symmetric fusion apparatus, with enhanced membrane interactions of variants explaining their unique cell fusion capacities and COVID-19 disease transmission rates.Entities:
Keywords: Protein structure aspects; Structural biology; Virology
Year: 2022 PMID: 35813872 PMCID: PMC9251956 DOI: 10.1016/j.isci.2022.104722
Source DB: PubMed Journal: iScience ISSN: 2589-0042
Figure 3Alignment of betacoronavirus spike protein sequences
Membrane-binding residues are highlighted in yellow for closed structures of SARS-CoV-1, bat and pangolin spike, or SARS-CoV-2 and its variants, with the latter being color-coded as shown in the bottom right key. Glycosylated and phosphorylated residue positions are indicated with “g” and “p.” The NTD, RBD and RBM boundaries are indicated by gray arrows. Residues that are within 4.5 Å of a bound ACE2 molecule in PDB 6lzg or that contact linoleic acid or biliverdin are indicated with upper bars colored purple, blue, and lavender, respectively. SARS-CoV-2 variant mutations are indicated above the sequences in uppercase black letters, with deletions and multiple variant mutations denoted by “X” and “/,” respectively, and an “EPE” insertion with an inverted triangle.
Mutations in variant SARS-CoV-2 spike protein NTD and RBD modules
| Variant | Membrane-binding positions | Beside a membrane-binding position in sequence | Close in space to a membrane binding residue |
|---|---|---|---|
| Alpha | ΔH69, ΔV70, ΔY144, N501Y | ||
| Beta | L18F, D80A, D215G, R246I, E484K, N501Y | ΔL241, ΔL242, ΔA243, K417N | |
| Gamma | L18F, T20N, P26S, R190S, E484K, N501Y | K417 N/T | D138Y |
| Delta | T19R, E156G, ΔF157, ΔR158, T478K | G142D, L452R | |
| Epsilon | W152C, L452R | ||
| Kappa | E154K, E484Q | G142D, L452R | |
| Omicron BA.1 | ΔH69, ΔV70, ΔV143, ΔY144, ΔY145, ΔN211, L212I, ins214EPE, G339D, S371L, S373P, S375F, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H | A67V, G142D, K417N | T95I |
| Omicron BA.2 | T19I, L24S, ΔP25, ΔP26, A27S, V213G, G339D, S371F, S373P, S375F, R408S, N440K, S477N, T478K, E484A, Q493R, Q498R, N501Y, Y505H | G142D, T376A, D405N, K417N | |
| Omicron BA.3 | ΔH69, ΔV70, ΔV143, ΔY144, ΔY145, ΔN211, L212I, G339D, S371F, S373P, S375F, D405N, N440K, G446S, S477N, T478K, E484A, Q493R, Q498R, N501Y, Y505H | A67V, G142D, K417N | T95I |
| Omicron BA.4 | T19I, L24S, ΔP25, ΔP26, A27S, ΔH69, ΔV70, V213G, G339D, S371F, S373P, S375F, R408S, N440K, S477N, T478K, E484A, F486V, Q498R, N501Y, Y505H | G142D, T376A, D405N, K417N, L452R | |
| Omicron BA.5 | T19I, L24S, ΔP25, ΔP26, A27S, ΔH69, ΔV70, V213G, G339D, S371F, S373P, S375F, R408S, N440K, S477N, T478K, E484A, F486V, Q498R, N501Y, Y505H | G142D, T376A, D405N, K417N, L452R |
Of the mutations identified in the NTD and RBM regions of these variants, most are in positions predicted by MODA to bind membranes directly, others are sequentially beside motifs predicted to bind membranes, and the remainder are spatially adjacent to residues that are predicted to bind membranes. The positions of these mutations are also shown in Figure 4, Figure 5, Figure 6, Figure 7, and mutations from BA.2, BA.3 (Desingu et al., 2022), BA.4 and BA.5 lineages (Yamasoba et al., 2022) of Omicron are also included here.
Figure 4Membrane-binding poses of variant spike protein trimers
The heatmaps show the membrane binding propensity of the residues in the Delta (A), Kappa (C), and Omicron BA.1 (E) spike trimer structures. RBD position and ACE2 occupancy are labeled left of the maps. Key motifs and mutations are labeled above and below, respectively. Positions are colored light blue–yellow–red to indicate MODA scores from 0 to 40 to 2000 as in the lower right scale, whereas gray indicates missing positions in the PDB files. The positions of the NTD, RBD, C-terminal domains (CTD) 1 and 2, fusion peptide (FP), heptad repeat 1 (HR1), central helix region (CH), and connector domain (CD) are shown above. The indicated conformational states are shown for the Delta (B), Kappa (D), and Omicron BA.1 (F) spike protein structures using PDBs listed above the viral membrane (gray slabs). The spike protein is tilted to position host membrane-binding interfaces above. Residues are labeled and colored pink-red based on MODA scores of 20– to 40+. The C-termini (C) connect to the viral membrane.
Figure 5Membrane-binding propensities of Alpha, Beta, Gamma, and Epsilon SARS-CoV-2 variant spike protein structures
Positions are colored light blue–yellow–red to indicate MODA scores from 0 to 40 to 2000, as indicated in the lower right scale, with residues missing in the indicated PDB files indicated in white within each vertical column. The up or down RBD positions (up or down arrows) and the absence or presence of ACE2 (minus or plus signs) are shown above the heatmap for the a, b, and c subunits of each trimer. The residue numbering is indicated on the left side along with the mutations found in the variants. The domain positions are shown on the right. The PDB entry names are shown below, with the Epsilon and Gamma closed spike ectodomain trimers modeled using I-TASSER (Zheng et al., 2021).
Figure 6Series of membrane-binding poses of Alpha, Beta, Gamma, and Epsilon variant spike structures
States of closed, one RBD up, two RBD up, and doubly or triply bound ACE2 molecules (ribbons) are shown, where available, for the trimeric Alpha (A), Beta (B), Gamma (C), and Epsilon (D) spike structures. The relevant PDB entry codes are labeled below. The host cell membrane and viral membrane are drawn as flat and curved gray slabs, respectively. The spike trimers are oriented to place the major membrane-binding surface near the host membrane and the C-termini toward the viral membrane. Residues are colored blue–pink–red on the surface depiction based on MODA scores of 0 to 20 to 40 + as in the lower scale.
Figure 7Structures of membrane-binding surfaces of SARS-CoV-2 variant spike trimers
(A) The fusion peptide elements that unusually exhibit membrane-binding propensity in this Omicron BA.1 spike trimer structure are labeled. The blue surface depicts residues that are labeled and colored pink-red based on MODA scores of 20 to 40+.
(B) membrane-binding surface on the outer edge of the closed Delta spike head. The T19R mutation in the Delta variant yields a membrane-binding NTD surface lined by Q14, V16-R21 and R246 that forms the top rim of the spike head. D142 influences the underlying β sheet and hairpin loop conformation and is near the position of deleted residues 157-158 and the E156G mutation. The latter residues precede the YHKNNKSWM sequence missing in this structure (PDB: 7v7n) but which displays significant MODA scores for Y145, H146, and K147, when present (PDB: 7w94). The membrane-interactive mutant residue R19 is in magenta and mutated D142, E157, S158, and G159 positions are color coded as shown.
(C) Open Delta variant structures bound to ACE2 receptors (aqua ribbons) with additional RBD inflections. The images show two and three RBD modules positioned up on the left and right, respectively. The viral and host cell membranes would be below and above, respectively.
(D) Membrane-binding surface on the rim of the Beta spike head. This largest continuous NTD membrane binding surface includes three mutated residues (magenta) as well as other residues exhibiting significant membrane-binding propensities (red) based on the MODA analysis.
Figure 1Membrane interaction sites in closed spike trimers of betacoronaviruses
The view is taken from the perspective of a host cell. Surfaces with all RBDs positioned down are shown for the bat and pangolin coronaviruses, SARS CoV-1, SARS CoV-2, Alpha, Beta, Delta, Kappa, Omicron BA.1 and BA.2, Gamma, and Epsilon variants. Residues in orange and red have MODA scores of 20–40 and over 40, respectively, in PDB files 5x58, 6zge, 7cn4, 7cn8, 7n1u, 7n1t, 7v7n, 7v7d, 7wk2, 7ub0, and I-TASSER models. The cartoon shows the positions of the peripheral NTD site (red trapezoids) and inner and outer RBD sites (red circles and diamonds with labeled motifs) that are predicted to bind host membranes in the three subunits that are colored yellow, green, and lavender.
Structural states of betacoronavirus and variant spike proteins
| Virus | Variant | RBD Position | State | MODA (RBD) | S-Dipole | Ligand | Resolution | PDB | Reference |
|---|---|---|---|---|---|---|---|---|---|
| SARS-CoV-2 | Alpha | 3 down | 1.0 | 6972 | 8154 | – | 3.14 | 7n1u | ( |
| SARS-CoV-2 | Alpha | 3 down | 1.0 | 5105 | 6369 | – | 3.22 | 7lws | ( |
| SARS-CoV-2 | Alpha | 1 up | 1.1 | 3939 | 7088 | – | 3.12 | 7lwv | ( |
| SARS-CoV-2 | Alpha | 1 up | 1.1 | 3437 | 7048 | – | 3.19 | 7lwt | ( |
| SARS-CoV-2 | Alpha | 1 up | 1.1 | 7119 | 6296 | – | 3.20 | 7edf | ( |
| SARS-CoV-2 | Alpha | 1 up | 1.1 | 4161 | 7170 | – | 3.20 | 7edg | ( |
| SARS-CoV-2 | Alpha | 1 up | 1.1 | 4329 | 8097 | – | 3.21 | 7n1v | ( |
| SARS-CoV-2 | Alpha | 1 up | 1.1 | 4677 | 7068 | – | 3.22 | 7lwu | ( |
| SARS-CoV-2 | Alpha | 1 up | 1.1 | 4292 | 8437 | – | 3.33 | 7n1w | ( |
| SARS-CoV-2 | Alpha | 2 up | 1.2 | 6311 | 6600 | – | 3.30 | 7edi | ( |
| SARS-CoV-2 | Alpha | 3 up | 5 | 349 | 14718 | 3 ACE2 | 3.30 | 7edj | ( |
| SARS-CoV-2 | Beta | 3 down | 1.0 | 6486 | 12,029 | – | 3.11 | 7n1t | ( |
| SARS-CoV-2 | Beta | 3 down | 1.0 | 5249 | 8692 | – | 3.57 | 7lym | ( |
| SARS-CoV-2 | Beta | 1 up | 1.1 | 5706 | 12287 | – | 2.90 | 7n1q | ( |
| SARS-CoV-2 | Beta | 1 up | 1.1 | 4235 | 9119 | – | 3.32 | 7lyo | ( |
| SARS-CoV-2 | Beta | 1 up | 1.1 | 4561 | 9070 | – | 3.32 | 7lyn | ( |
| SARS-CoV-2 | Beta | 1 up | 1.1 | 4274 | 9231 | – | 3.34 | 7lyq | ( |
| SARS-CoV-2 | Beta | 1 up | 1.1 | 7916 | 9724 | – | 3.20 | 7v76 | ( |
| SARS-CoV-2 | Beta | 1 up | 1.1 | 7853 | 9757 | – | 3.40 | 7v8c | ( |
| SARS-CoV-2 | Beta | 1 up | 1.1 | 8440 | 10227 | – | 3.50 | 7vx1 | ( |
| SARS-CoV-2 | Beta | 2 up | 1.2 | 7894 | 9839 | – | 3.30 | 7v77 | ( |
| SARS-CoV-2 | Gamma | 3 down | 1.0 | 6856 | 21272 | – | – | I-TASSER | ( |
| SARS-CoV-2 | Gamma | 1 up | 1.1 | 6425 | 10446 | – | 3.30 | 7v79 | ( |
| SARS-CoV-2 | Gamma | 1 up | 1.1 | 7057 | 10411 | – | 3.40 | 7v78 | ( |
| SARS-CoV-2 | Gamma | 2 up | 1.2 | 6807 | 10650 | – | 3.40 | 7v7a | ( |
| SARS-CoV-2 | Gamma | 3 up | 1.3 | n.a. | n.a. | – | 3.50 | n.a. | ( |
| SARS-CoV-2 | Gamma | 2 up | 4.2 | 1836 | 7698 | 2 ACE2 | 3.20 | 7v81 | ( |
| SARS-CoV-2 | Gamma | 3 up | 5 | 368 | 11098 | 3 ACE2 | 2.80 | 7v82 | ( |
| SARS-CoV-2 | Gamma | 3 up | 5 | 193 | 10939 | 3 ACE2 | 2.80 | 7v83 | ( |
| SARS-CoV-2 | Delta | 3 down | 1.0 | 6829 | 10023 | – | 2.90 | 7v7n | ( |
| SARS-CoV-2 | Delta | 3 down | 1.0 | 4610 | 10948 | – | 3.10 | 7sbk | ( |
| SARS-CoV-2 | Delta | 3 down | 1.0 | 5805 | 11522 | – | 3.40 | 7w94 | ( |
| SARS-CoV-2 | Delta | 1 up | 1.1 | n.a. | 8346 | – | 2.25 | 7tey | ( |
| SARS-CoV-2 | Delta | 1 up | 1.1 | 3981 | 10466 | – | 2.80 | 7v7q | ( |
| SARS-CoV-2 | Delta | 1 up | 1.1 | 3916 | 10350 | – | 2.90 | 7v7p | ( |
| SARS-CoV-2 | Delta | 1 up | 1.1 | 4189 | 10324 | – | 2.90 | 7v7o | ( |
| SARS-CoV-2 | Delta | 1 up | 1.1 | 3859 | 10624 | – | 2.90 | 7v7r | ( |
| SARS-CoV-2 | Delta | 1 up | 1.1 | 4161 | 10597 | – | 3.00 | 7v7s | ( |
| SARS-CoV-2 | Delta | 1 up | 1.1 | 4282 | 11683 | – | 3.10 | 7w92 | ( |
| SARS-CoV-2 | Delta | 1 up | 1.1 | n.a | 8623 | – | 3.16 | 7tov | ( |
| SARS-CoV-2 | Delta | 1 up | 1.1 | 5653 | 8185 | – | 3.24 | 7tou | ( |
| SARS-CoV-2 | Delta | 1 up | 1.1 | 3880 | 11407 | – | 3.40 | 7sbl | ( |
| SARS-CoV-2 | Delta | 1 up | 1.1 | n.a. | 8690 | – | 3.40 | 7tpf | ( |
| SARS-CoV-2 | Delta | 1 up | 1.1 | n.a. | 8724 | – | 3.40 | 7tp8 | ( |
| SARS-CoV-2 | Delta | 1 up | 1.1 | n.a. | 8575 | – | 3.48 | 7tp7 | ( |
| SARS-CoV-2 | Delta | 1 up | 1.1 | n.a. | 8626 | – | 3.48 | 7tp9 | ( |
| SARS-CoV-2 | Delta | 2 up | 1.2 | 4124 | 10797 | – | 3.00 | 7v7t | ( |
| SARS-CoV-2 | Delta | 2 up | 1.2 | 3310 | 10880 | – | 3.10 | 7v7v | ( |
| SARS-CoV-2 | Delta | 2 up | 1.2 | 4141 | 10990 | – | 3.00 | 7v7u | ( |
| SARS-CoV-2 | Delta | 1 up | 3.1 | n.a. | 4559 | 1 ACE2 | 3.27 | 7tex | ( |
| SARS-CoV-2 | Delta | 2 up | 3.2 | 4381 | 5863 | 1 ACE2 | 3.40 | 7w9b | ( |
| SARS-CoV-2 | Delta | 3 up | 3.3 | 4470 | 6052 | 1 ACE2 | 3.20 | 7w9c | ( |
| SARS-CoV-2 | Delta | 3 up | 3.3 | 2886 | 5489 | 1 ACE2 | 3.40 | 7w99 | ( |
| SARS-CoV-2 | Delta | 2 up | 4.2 | 954 | 8318 | 2 ACE2 | 3.30 | 7v88 | ( |
| SARS-CoV-2 | Delta | 3 up | 5 | 33 | 11273 | 3 ACE2 | 2.70 | 7v8a | ( |
| SARS-CoV-2 | Delta | 3 up | 5 | 48 | 11342 | 3 ACE2 | 2.80 | 7v89 | ( |
| SARS-CoV-2 | Epsilon | 3 down | 1.0 | 5369 | 20498 | – | – | I-TASSER | ( |
| SARS-CoV-2 | Kappa | 3 down | 1.0 | 5191 | 11970 | – | 3.00 | 7v7d | ( |
| SARS-CoV-2 | Kappa | 3 down | 1.0 | 7989 | 13648 | – | 3.10 | 7sbp | ( |
| SARS-CoV-2 | Kappa | 1 up | 1.1 | n.a. | 8513 | – | 2.25 | 7tf3 | ( |
| SARS-CoV-2 | Kappa | 1 up | 1.1 | 4684 | 12251 | – | 2.90 | 7v7e | ( |
| SARS-CoV-2 | Kappa | 1 up | 1.1 | 4171 | 12146 | – | 2.90 | 7v7f | ( |
| SARS-CoV-2 | Kappa | 1 up | 1.1 | 5605 | 11621 | – | 3.20 | 7vxe | ( |
| SARS-CoV-2 | Kappa | 2 up | 1.2 | 5710 | 12597 | – | 3.10 | 7v7g | ( |
| SARS-CoV-2 | Kappa | 2 up | 3.2 | n.a. | 3864 | 1 ACE2 | 3.02 | 7tf0 | ( |
| SARS-CoV-2 | Kappa | 2 up | 4.2 | 651 | 6318 | 2 ACE2 | 3.30 | 7v85 | ( |
| SARS-CoV-2 | Kappa | 3 up | 5 | 35 | 9798 | 3 ACE2 | 2.80 | 7v86 | ( |
| SARS-CoV-2 | Omicron BA.1 | 3 down | 1.0 | 9172 | 9758 | – | 2.56 | 7wp9 | ( |
| SARS-CoV-2 | Omicron BA.1 | down | 1.0 | n.a. | 7853 | – | 2.79 | 7t9j | ( |
| SARS-CoV-2 | Omicron BA.1 | 3 down | 1.0 | 4836 | 10765 | – | 3.10 | 7wk2 | ( |
| SARS-CoV-2 | Omicron BA.1 | 3 down | 1.0 | 3520 | 11247 | – | 3.10 | 7tnw | ( |
| SARS-CoV-2 | Omicron BA.1 | 3 down | 1.0 | 8660 | 9548 | – | 3.36 | 7tf8 | ( |
| SARS-CoV-2 | Omicron BA.1 | 3 down | 1.0 | 8676 | 9460 | – | 3.50 | 7tl1 | ( |
| SARS-CoV-2 | Omicron BA.1 | 1 up | 1.1 | 9244 | 11403 | – | 3.00 | 7tgw | ( |
| SARS-CoV-2 | Omicron BA.1 | 1 up | 1.1 | 5382 | 12246 | – | 3.02 | 7qo7 | ( |
| SARS-CoV-2 | Omicron BA.1 | 1 up | 1.1 | 11654 | 6923 | – | 3.11 | 7thk | ( |
| SARS-CoV-2 | Omicron BA.1 | 1 up | 1.1 | 9475 | 10391 | – | 3.29 | 7tb4 | ( |
| SARS-CoV-2 | Omicron BA.1 | 1 up | 1.1 | 5329 | 11097 | – | 3.40 | 7wk3 | n.a. |
| SARS-CoV-2 | Omicron BA.1 | 1 up | 1.1 | 9587 | 12937 | – | 3.40 | 7wg6 | ( |
| SARS-CoV-2 | Omicron BA.1 | 1 up | 1.1 | 6242 | 11702 | – | 3.40 | 7to4 | ( |
| SARS-CoV-2 | Omicron BA.1 | 1 up | 1.1 | n.a. | n.a. | – | 3.40 | 7tei | ( |
| SARS-CoV-2 | Omicron BA.1 | 1 up | 1.1 | 6237 | 11215 | – | 3.40 | 7wvn | ( |
| SARS-CoV-2 | Omicron BA.1 | 1 up | 1.1 | 3911 | 9486 | – | 3.41 | 7wvo | ( |
| SARS-CoV-2 | Omicron BA.1 | 1 up | 1.1 | 9654 | 10175 | – | 3.50 | 7tl9 | ( |
| SARS-CoV-2 | Omicron BA.1 | 1 up | 3.1 | 1885 | 4158 | 1 ACE2 | 2.77 | 7wpa | ( |
| SARS-CoV-2 | Omicron BA.1 | 1 up | 3.1 | 2440 | 2511 | 1 ACE2 | 2.90 | 7ws9 | ( |
| SARS-CoV-2 | Omicron BA.1 | 1 up | 3.1 | 3085 | 3906 | 1 ACE2 | 3.13 | 7xo5 | ( |
| SARS-CoV-2 | Omicron BA.1 | 1 up | 3.1 | 3423 | 4672 | 1 ACE2 | 3.69 | 7wk4 | ( |
| SARS-CoV-2 | Omicron BA.1 | 2 up | 3.2 | 5184 | 5256 | 1 ACE2 | 3.66 | 7wk5 | ( |
| SARS-CoV-2 | Omicron BA.1 | 2 up | 3.2 | 5261 | 5243 | 1 ACE2 | 3.70 | 7wvp | ( |
| SARS-CoV-2 | Omicron BA.1 | 3 up | 3.3 | 7420 | 5770 | 1 ACE2 | 4.04 | 7wvq | ( |
| SARS-CoV-2 | Omicron BA.1 | 2 up | 4.2 | 542 | 8309 | 2 ACE2 | 2.45 | 7t9k | ( |
| SARS-CoV-2 | Omicron BA.1 | 2 up | 4.2 | 1070 | 7679 | 2 ACE2 | 3.00 | 7ws8 | ( |
| SARS-CoV-2 | Omicron BA.1 | 2 up | 4.2 | 953 | 4278 | 2 ACE2 | 3.24 | 7xo4 | ( |
| SARS-CoV-2 | Omicron BA.1 | 2 up | 4.2 | 2523 | 9770 | 2 ACE2 | 3.30 | 7xid | ( |
| SARS-CoV-2 | Omicron BA.1 | monomer | n.a. | 9216 | n.a. | – | – | Robetta | ( |
| SARS-CoV-2 | Omicron BA.2 | 3 down | 1.0 | 6356 | 10173 | – | 3.31 | 7ub0 | ( |
| SARS-CoV-2 | Omicron BA.2 | 3 down | 1.0 | 5908 | 9760 | – | 3.35 | 7ub5 | ( |
| SARS-CoV-2 | Omicron BA.2 | 3 down | 1.0 | 6571 | 10146 | – | 3.52 | 7ub6 | ( |
| SARS-CoV-2 | Omicron BA.2 | 1 up | 3.1 | 2537 | 3265 | 1 ACE2 | 3.20 | 7xoa | ( |
| SARS-CoV-2 | Omicron BA.2 | 2 up | 4.2 | 511 | 4683 | 2 ACE2 | 3.30 | 7xob | ( |
| SARS-CoV-2 | Omicron BA.2 | 2 up | 4.2 | 1011 | 7916 | 2 ACE2 | 3.38 | 7xo7 | ( |
| SARS-CoV-2 | Omicron BA.2 | 3 up | 5 | 619 | 12139 | 3 ACE2 | 3.48 | 7xo8 | ( |
| SARS-CoV-2 | Omicron BA.2 | monomer | n.a. | 11796 | n.a. | – | – | Robetta | ( |
| SARS-CoV-2 | Omicron BA.3 | monomer | n.a. | 10121 | n.a. | – | – | Robetta | ( |
| SARS-CoV-2 | Omicron BA.4 | monomer | n.a. | 5180 | n.a. | – | – | Robetta | ( |
| SARS-CoV-2 | Omicron BA.5 | monomer | n.a. | 5180 | n.a. | – | – | Robetta | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | 4678 | 7486 | – | 2.40 | 6xlu | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | 3341 | 7377 | – | 2.50 | 7jwy | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | 3928 | 9583 | – | 2.60 | 6zge | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | 2384 | 9255 | – | 2.70 | 7df3 | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | 5017 | 6980 | – | 2.80 | 6vxx | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | 4538 | 7459 | – | 2.80 | 7kdk | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | n.a. | 7675 | – | 2.83 | 7tlc | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | n.a. | 7619 | – | 2.89 | 7tld | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | n.a. | 7737 | – | 3.06 | 7tlb | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | n.a. | 7667 | – | 3.13 | 7tla | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | n.a. | 4396 | – | 2.90 | 6x79 | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | 3522 | 9695 | – | 2.90 | 6xr8 | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | 3866 | 9624 | – | 2.90 | 6zgi | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | 2694 | 9430 | – | 3.00 | 7ddd | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | n.a. | 7808 | – | 3.00 | 6zow | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | 3197 | 7711 | – | 3.01 | 7kdg | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | 6960 | 8057 | – | 3.10 | 6xm5 | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | 2094 | 7223 | – | 3.22 | 6x6p | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | 4904 | 9607 | Biliverdin | 2.85 | 7nta | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | 4229 | 9007 | Biliverdin | 3.60 | 7nt9 | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | 2893 | 6693 | Linoleic acid | 2.27 | 7qur | n.a. |
| SARS-CoV-2 | – | 3 down | 1.0 | 2658 | 9491 | Linoleic acid | 2.70 | 7dwy | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | 2823 | 6982 | Linoleic acid | 2.85 | 6zb5 | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | 3915 | 7050 | Linoleic acid | 3.03 | 6zb4 | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | 2750 | 9644 | Linoleic acid | 3.60 | 7jji | ( |
| SARS-CoV-2 | – | 3 down | 1.0 | 2716 | 8618 | Steric acid | 3.10 | 7z3z | ( |
| SARS-CoV-2 | – | 1 up | 1.1 | 3085 | 8592 | – | 2.50 | 6xm3 | ( |
| SARS-CoV-2 | – | 1 up | 1.1 | 3,225 | 8231 | – | 2.50 | 6xm4 | ( |
| SARS-CoV-2 | – | 1 up | 1.1 | 2845 | 8022 | – | 2.70 | 6xm0 | ( |
| SARS-CoV-2 | – | 1 up | 1.1 | 2577 | 7887 | – | 3.10 | 6zp5 | ( |
| SARS-CoV-2 | – | 1 up | 1.1 | 6205 | 8574 | – | 3.30 | 7dwz | ( |
| SARS-CoV-2 | – | 1 up | 1.1 | 7378 | 7918 | – | 3.50 | 7eaz | ( |
| SARS-CoV-2 | – | 1 up | 1.1 | 346 | 8675 | – | 3.10 | 7dx1 | ( |
| SARS-CoV-2 | – | 1 up | 1.1 | 382 | 8416 | – | 3.20 | 6vyb | ( |
| SARS-CoV-2 | – | 1 up | 1.1 | n.a. | 7760 | – | 3.30 | 6zp7 | ( |
| SARS-CoV-2 | – | 1 up | 1.1 | 4128 | 7480 | – | 3.40 | 6z97 | ( |
| SARS-CoV-2 | – | 1 up | 1.1 | 1869 | 6883 | – | 3.46 | 6vsb | ( |
| SARS-CoV-2 | – | 3 up | 3.3 | 301 | 4868 | 1 ACE2 | 3.00 | 7dx6 | ( |
| SARS-CoV-2 | – | 3 up | 3.3 | 214 | 4535 | 1 ACE2 | 3.30 | 7dx5 | ( |
| SARS-CoV-2 | – | 3 up | 3.3 | 1966 | 4349 | 1 ACE2 | 3.85 | 7kne | ( |
| SARS-CoV-2 | – | 3 up | 4.3 | 1129 | 8495 | 2 ACE2 | 3.74 | 7knh | ( |
| SARS-CoV-2 | – | 3 up | 4.3 | 1301 | 8519 | 2 ACE2 | 3.62 | 7kmz | ( |
| SARS-CoV-2 | – | 3 up | 5 | 476 | 12087 | 3 ACE2 | 3.91 | 7kni | ( |
| SARS-CoV-2 | – | 3 up | 5 | 291 | 11911 | 3 ACE2 | 3.64 | 7kms | ( |
| SARS-CoV-1 | – | 3 down | 1.0 | 3368 | 1689 | – | 3.20 | 5x58 | ( |
| SARS-CoV-1 | – | 3 down | 1.0 | 3910 | 3496 | – | 3.80 | 5xlr | ( |
| SARS-CoV-1 | – | 1 up | 1.1 | 3751 | 3073 | – | 3.30 | 6crz | ( |
| Pangolin CoV | – | 3 down | 1.0 | 607 | 7429 | – | 2.50 | 7cn8 | ( |
| Pangolin CoV | – | 3 down | 1.0 | 3688 | 7205 | – | 2.90 | 7bbh | ( |
| Bat CoV | RaTG13 | 3 down | 1.0 | 1494 | 4745 | – | 2.93 | 7cn4 | ( |
| Bat CoV | RaTG13 | 3 down | 1.0 | 1379 | 6851 | – | 3.10 | 6zgf | ( |
Only the higher resolution structures analyzed in this study are listed, along with the orientation of the RBD modules, conformational state (as depicted in Figure 8), dipole moment (Debyes), names and numbers of bound ligand molecules, resolution (Å), PDB code, and reference. Where information is not available such as in the case of a missing PDB file or a lack of substantial structure, “n.a.” is shown.
Figure 8Progressive model of the spike:membrane attachment mechanism
A single spike trimer is shown to depict the multiple states that populate the SARS-CoV-2 surface. The three unbound RBDs flicker between up and down states (tall and short blue rectangles, respectively) to yield interconverting spike states 1.0, 1.1, 1.2, and 1.3. Also drawn are the NTDs (blue triangles) and remainder of the S subunits (blue line) that span the viral membrane (light gray bar). The host cell membrane (dark red bars) is engaged in states 2 and above, and may lead to ACE2-independent fusion of viral particle and host cell membranes via the symmetric RBD-up state 2.3 (black arrows). The membrane-tethered spike trimer can bind a single ACE2 receptor (green circle) on the host cell surface either in state 3.1, 3.2, or 3.3, and then a second ACE2 molecule in state 4.2 or 4.3, and finally a third ACE2 molecule to form the canonical prefusion assembly state 5. Based on cryo-EM image distributions, the states that may be preferentially populated in Gamma, Delta, Omicron BA.1, or any variant are connected by gold, orange, magenta, and red arrows, respectively.
Figure 2Betacoronavirus and variant spike membrane-binding elements
(A) The membrane-binding propensities of pangolin, bat, SARS-CoV-1, CoV-2 wild-type as well as of cariant CoV-2 Alpha, Beta, Gamma, Delta, Epsilon, Kappa, and Omicron BA.1 spike protein residues are shown. Motifs that have substantial MODA scores are labeled on the right using the founder SARS-CoV-2 sequence. Positions are colored light blue–yellow–red to indicate MODA scores from 0 to 40 to 2000 as in the lower right scale.
(B) The total MODA scores of residues in membrane-binding motifs in the single-up and all-down RBDs are shown in an increasing order. The closed trimer scores are for PDB files indicated in (A), except for Omicron BA.1 and BA.2 that are taken from 7wp9 and 7ub0, respectively. The open trimer scores are taken from the three highest resolution RBDs with fully resolved structures.
(C) The RBD structures from wild type SARS-CoV-2 and five variants shown in (A) are superimposed and color-coded. The sidechains of Omicron BA.1 residues with MODA scores over 20 are shown to depict its major membrane-binding surface.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| CoV3D database | ( | Listing of spike protein structures |
| Structures of spikes | ( | PDB entries 5x58, 5xlr, 6crz, 6vsb, 6vxx, 6vyb, 6x6p, 6x79, 6xlu, 6xm0, 6xm3, 6xm4, 6xm5, 6xr8, 6z97, 6zb4, 6zb5, 6zge, 6zgf, 6zgi, 6zow, 6zp5, 6zp7, 7bbh, 7cn4, 7cn8, 7ddd, 7df3, 7dwy, 7dwz, 7dx1, 7dx5, 7dx6, 7eaz, 7edf, 7edg, 7edi, 7edj, 7jji, 7jwy, 7kdg, 7kdk, 7kms, 7kmz, 7kne, 7knh, 7kni, 7lws, 7lwt, 7lwu, 7lwv, 7lym, 7lyn, 7lyo, 7lyq, 7n1q, 7n1t, 7n1u, 7n1v, 7n1w, 7nt9, 7nta, 7qo7, 7qur, 7sbk, 7sbl, 7sbp, 7t9j, 7t9k, 7tb4, 7tei, 7tex, 7tey, 7tf0, 7tf3, 7tf8, 7tgw, 7thk, 7tl1, 7tl9, 7tla, 7tlb, 7tlc, 7tld, 7tnw, 7to4, 7tou, 7tov, 7tp7, 7tp8, 7tp9, 7tpf, 7ub0, 7ub5, 7ub6, 7v76, 7v77, 7v78, 7v79, 7v7a, 7v7d, 7v7e, 7v7f, 7v7g, 7v7n, 7v7o, 7v7p, 7v7q, 7v7r, 7v7s, 7v7t, 7v7u, 7v7v, 7v81, 7v82, 7v83, 7v85, 7v86, 7v88, 7v89, 7v8a, 7v8c, 7vx1, 7vxe, 7w92, 7w94, 7w99, 7w9b, 7w9c, 7wg6, 7wk2, 7wk3, 7wk4, 7wk5, 7wp9, 7wpa, 7ws8, 7ws9, 7wvn, 7wvo, 7wvp, 7wvq, 7xid, 7xo4, 7xo5, 7xo7, 7xo8, 7xoa, 7xob, 7z3z |
| Uniprot database | ( | Spike protein sequences QHR63300.2, A0A6G6A2Q2, P59594 and P0DTC2 |
| Clustal Omega program | ( | |
| ICM Browser program | ( | |
| I-TASSER program | ( | |
| Jalview 2 program | ( | |
| MODA program | ( | |
| PPM 3.0 program | ( | |
| Protein Dipole Moments Server | ( | |
| Pymol program | ( | |
| Robetta program | ( | |